ID: ALA4446986

Max Phase: Preclinical

Molecular Formula: C15H13N3O

Molecular Weight: 251.29

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cc2nnn(C(=O)c3ccccc3)c2cc1C

Standard InChI:  InChI=1S/C15H13N3O/c1-10-8-13-14(9-11(10)2)18(17-16-13)15(19)12-6-4-3-5-7-12/h3-9H,1-2H3

Standard InChI Key:  BIWLDPOPZDFCEM-UHFFFAOYSA-N

Associated Targets(Human)

Alpha glucosidase 860 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 251.29Molecular Weight (Monoisotopic): 251.1059AlogP: 2.74#Rotatable Bonds: 1
Polar Surface Area: 47.78Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.50CX LogD: 3.50
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.67Np Likeness Score: -1.57

References

1. Hameed S, Kanwal, Seraj F, Rafique R, Chigurupati S, Wadood A, Rehman AU, Venugopal V, Salar U, Taha M, Khan KM..  (2019)  Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.,  183  [PMID:31514061] [10.1016/j.ejmech.2019.111677]

Source